HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,258,658 | -41.3% | 5,047,000 | -42.2% | 0.01% | -45.5% |
| Q2 2023 | $7,254,998 | -4.3% | 8,735,000 | -2.4% | 0.01% | -8.3% |
| Q1 2023 | $7,581,796 | -10.7% | 8,946,000 | +2.1% | 0.01% | -20.0% |
| Q4 2022 | $8,486,583 | +2.7% | 8,766,000 | -10.3% | 0.02% | -6.2% |
| Q3 2022 | $8,266,000 | -0.6% | 9,768,000 | +3.6% | 0.02% | +6.7% |
| Q2 2022 | $8,319,000 | +3.7% | 9,430,000 | +2.4% | 0.02% | +25.0% |
| Q1 2022 | $8,026,000 | – | 9,212,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |